SCM
Silverarc Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,121
| Closed | -$340K | – | 82 |
|
|
2025
Q1 | $340K | Buy |
+10,121
| New | +$340K | 0.07% | 63 |
|
|
2024
Q2 | – | Sell |
-66,090
| Closed | -$2.85M | – | 84 |
|
|
2024
Q1 | $2.85M | Sell |
66,090
-97,078
| -59% | -$4.18M | 0.79% | 38 |
|
|
2023
Q4 | $7.52M | Buy |
163,168
+109,172
| +202% | +$5.03M | 2.24% | 15 |
|
|
2023
Q3 | $1.84M | Sell |
53,996
-45,760
| -46% | -$1.56M | 0.56% | 40 |
|
|
2023
Q2 | $3.84M | Buy |
99,756
+3,113
| +3% | +$120K | 1.19% | 26 |
|
|
2023
Q1 | $3.46M | Sell |
96,643
-157,012
| -62% | -$5.62M | 1.43% | 24 |
|
|
2022
Q4 | $10M | Buy |
253,655
+7,663
| +3% | +$302K | 2.86% | 5 |
|
|
2022
Q3 | $8.88M | Buy |
245,992
+13,362
| +6% | +$482K | 3% | 7 |
|
|
2022
Q2 | $7.08M | Buy |
232,630
+131,549
| +130% | +$4M | 2.18% | 11 |
|
|
2022
Q1 | $1.43K | Buy |
101,081
+1,081
| +1% | +$15 | 0.59% | 41 |
|
|
2021
Q4 | $3.12M | Buy |
100,000
+80,568
| +415% | +$2.52M | 1.27% | 26 |
|
|
2021
Q3 | $297K | Buy |
+19,432
| New | +$297K | 0.17% | 74 |
|